Factors Contributing to Medication Adherence in Patients with a Chronic Condition: A Scoping Review of Qualitative Research
Open accessThe DOI matches its Crossref record; 86 of the 87 references it cites were found in a registry or an index; 9 of the 16 sources its claims cite were checked for support.
Abstract
INTRODUCTION: Medication adherence continues to be a significant challenge in healthcare, and there is a shortage of effective interventions in this area. This scoping review studied the patient-related factors of medication adherence. METHODS: We searched Medline Ovid, Scopus, and Cochrane Library from January 2009 to June 2021 to find the most recent original qualitative studies or systematic reviews that addressed the patient-related factors of medication adherence in treating chronic conditions. We used the PRISMA-ScR checklist to ensure the quality of the study. RESULTS: The initial search revealed 4404 studies, of which we included 89 qualitative studies in the scoping review. We inductively organized the patient-related factors causing barriers, as well as the facilitators to medication adherence. The studies more often dealt with barriers than facilitators. We classified the factors as patient-specific, illness-specific, medication-related, healthcare and system-related, sociocultural, as well as logistical and financial factors. Information and knowledge of diseases and their treatment, communication, trust in patient-provider relationships, support, and adequate resources appeared to be the critical facilitators in medication adherence from the patient perspective. DISCUSSION AND CONCLUSIONS: Patients are willing to discuss their concerns about medications. Better communication and better information on medicines appear to be among the critical factors for patients. The findings of this scoping review may help those who plan further interventions to improve medication adherence.
Overview
CoChat Summary
## TL;DR
This scoping review synthesized qualitative evidence on why patients with chronic conditions do or do not adhere to medication, including 89 original peer-reviewed studies and 13 prior systematic reviews. It found that barriers were reported more often than facilitators, and that information, communication, trust, support, and practical resources were central to adherence.
## Key findings
- The review included 89 original peer-reviewed qualitative articles and 13 systematic reviews; the original studies came from 36 countries.
- The evidence was organized into six barrier domains: patient-specific, illness-specific, medication-related, healthcare/system-related, sociocultural, and logistical/financial factors.
- The evidence was organized into five facilitator domains: information/knowledge, individual and social motivation, behavioural skills, healthcare/system factors, and logistical/financial factors.
- The authors report that studies more often dealt with barriers than facilitators; they also note 17 studies used a behaviour-theory-based approach.
## Methods
- Design: Scoping review of qualitative research, reported using PRISMA-ScR.
- Data/sample: Searches of MEDLINE (Ovid), Scopus, and the Cochrane Library were run on 23 September 2019 and updated on 9 June 2021; included studies were published from January 2009 to June 2021, in English, and in peer-reviewed journals.
- Analysis: Titles/abstracts and full texts were screened by multiple reviewers in Covidence; the team did not assess risk of bias; data were extracted independently by two reviewers and then inductively categorized into barrier/facilitator themes, with the IMB model used as part of the facilitator classification.
## Limitations
- The paper states that, because it focused on qualitative aspects, it cannot conclude the magnitude of the effect of the factors influencing adherence.
- The search was limited to English-language studies, which the authors say may be a source of bias.
- The authors note that the review found more barriers than facilitators, which they call a limitation, though they also interpret this as reflecting the literature’s greater focus on barriers.
- Evident from the text: the review excluded studies before 2009, so older qualitative evidence is not covered.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
7 Valid · 1 Not valid · 3 Not checked · 39 Own results and interpretations
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“The same factors that improve medication adherence may also decrease it [9,10,11].”
§ Factors Contributing to Medication Adherence in Patients with a Chronic Condition: A Scoping Review of Qualitative Research > 1. Introduction
What the sources say
- Not checked — no full text of the sourcecites [9] Bauler S. Jacquin-Courtois S. Haesebaert J. Luaute J. Coudeyre E. Feutrier C. Allenet B. Decullier E. Rode G. Janoly-Dumenil A. Barriers and facilitators for medication adherence in stroke patients: A qualitative study conducted in french neurological rehabilitation units Eur. Neurol. 2014 72 262 270 10.1159/000362718 25277833 source
- Supportedcites [10] Nielsen T.M. Juhl M.F. Feldt-Rasmussen B. Thomsen T. Adherence to medication in patients with chronic kidney disease: A systematic review of qualitative research Clin. Kidney J. 2018 11 513 527 10.1093/ckj/sfx140 30094015 PMC6070096 source
The Discussion (page not supplied) says that dosette boxes and memory tools may affect adherence both positively and negatively. It explains that these tools can help forgetful patients but may be barriers for patients with impaired vision, sensory disturbances or reading difficulties. (LLM, conf=0.92)
- Supportedcites [11] Rezaei M. Valiee S. Tahan M. Ebtekar F. Gheshlagh R.G. Barriers of medication adherence in patients with type-2 diabetes: A pilot qualitative study Diabetes Metab. Syndr. Obes. Targets Ther. 2019 12 589 599 10.2147/DMSO.S197159 PMC6507070 31118722 source
The Discussion (page unavailable) says family trust and support can improve adherence. The Results, under “Interactive/economic challenges” (page unavailable), describe how an unsupportive partner can discourage regular medication use. Together, these passages support the claim that family-related factors can affect adherence in either direction. (LLM, conf=0.86)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We identified similar factors to medication adherence in the previous systematic qualitative reviews (n = 13, Table A2) as in the qualitative studies described above (n = 76, Table A1).”
§ Factors Contributing to Medication Adherence in Patients with a Chronic Condition: A Scoping Review of Qualitative Research > 3. Results > 3.3. Summary of Findings
plainn = 76- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The studies more often dealt with barriers than facilitators.”
- Also stated in: § 3.1. Barriers to Medication Adherence · plain
“Overall, the studies reported more barriers than facilitators to medication adherence.”
- Also stated in: § 3.3. Summary of Findings · plain
“the studies were more often concerned with barriers than facilitators.”
§ Factors Contributing to Medication Adherence in Patients with a Chronic Condition: A Scoping Review of Qualitative Research > Abstract
plainn = 89- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § 3.1. Barriers to Medication Adherence · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We classified the factors as patient-specific, illness-specific, medication-related, healthcare and system-related, sociocultural, as well as logistical and financial factors.”
- Also stated in: § 3.1. Barriers to Medication Adherence · plain
“We inductively identified six subject areas with subcategories related to barriers to medication adherence based on the included qualitative studies (n = 89).”
§ Factors Contributing to Medication Adherence in Patients with a Chronic Condition: A Scoping Review of Qualitative Research > Abstract
plainn = 89- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § 3.1. Barriers to Medication Adherence · plain
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“However, external circumstances affect adherence, such as financial problems or poor access to care, which have to be considered.”
§ Factors Contributing to Medication Adherence in Patients with a Chronic Condition: A Scoping Review of Qualitative Research > 4. Discussion > 4.1. Main Findings
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
13 more claims
Create a free account to see all 50 claims and to verify the 1 reference still open.
- It may state two separate claims as one. 16
- Probably not a substantial claim. 21
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Restrictive conditions for the intake of oral medications may adversely affect treatment adherence and compliance and, consequently, patient outcomes [23,24].”
Citations
Cites
PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation
Tricco, A. C., Lillie, E., Zarin, W., O'Brien, K. K., Colquhoun, H., Levac, D., Moher, D., Peters, M. D. J., Horsley, T., Weeks, L., et al. (2018) · Annals of Internal Medicine · doi:10.7326/m18-0850 · Cited by 43,565
Human error: models and management
Reason, J. (2000) · BMJ · doi:10.1136/bmj.320.7237.768 · Cited by 5,665
Interventions for enhancing medication adherence
Nieuwlaat, R., Wilczynski, N., Navarro, T., Hobson, N., Jeffery, R., Keepanasseril, A., Agoritsas, T., Mistry, N., Iorio, A., Jack, S., et al. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000011.pub4 · Cited by 2,945 · cited 2×
“have combined the existing evidence of adherence interventions [3].”
BackgroundFisher, J. D., & Fisher, W. A. (1992) · Psychological Bulletin · doi:10.1037/0033-2909.111.3.455 · Cited by 2,459
Updated methodological guidance for the conduct of scoping reviews
Peters, M. D. J., Marnie, C., Tricco, A. C., Pollock, D., Munn, Z., Alexander, L., McInerney, P., Godfrey, C. M., & Khalil, H. (2021) · JBI Evidence Implementation · doi:10.1097/xeb.0000000000000277 · Cited by 1,461
Interventions for enhancing medication adherence
Haynes, R. B., Ackloo, E., Sahota, N., McDonald, H. P., & Yao, X. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000011.pub3 · Cited by 1,244
Rasmussen, J. N., Chong, A., & Alter, D. A. (2007) · JAMA · doi:10.1001/jama.297.2.177 · Cited by 975
Economic impact of medication non-adherence by disease groups: a systematic review
Cutler, R. L., Fernandez-Llimos, F., Frommer, M., Benrimoj, C., & Garcia-Cardenas, V. (2018) · BMJ Open · doi:10.1136/bmjopen-2017-016982 · Cited by 900
Adherence and health care costs
McGuire, M., & Iuga (2014) · Risk Management and Healthcare Policy · doi:10.2147/rmhp.s19801 · Cited by 708
Velligan, D. I., Weiden, P. J., Sajatovic, M., Scott, J. L., Carpenter, D., Ross, R., & Docherty, J. P. (2009) · PubMed · Cited by 625
Cited by
Items 301–400 of 470
DIFFERENT METHODS OF ADHERENCE TO THERAPY IN PATIENTS WITH RESISTANT HYPERTENSION (PILOT STUDY)
Rekovets, О. L., & Sirenko, Y. (2023) · Clinical & experimental pathology · doi:10.24061/1727-4338.xxii.1.83.2023.05
(2023) · Oxford University Press eBooks · doi:10.1093/med/9780197556269.002.0007
Lithovius, R., Mutter, S., Parente, E. B., Harjutsalo, V., Groop, P., Thorn, L. M., & Sandholm, N. (2025) · Acta Diabetologica · doi:10.1007/s00592-025-02610-3
Managing patients with sex-, race-, or ethnicity-based cardiovascular health inequities
Luntz, A., Creary, K., & Bruessow, D. (2023) · JAAPA · doi:10.1097/01.jaa.0000937264.73482.83 · Cited by 1
Non–cost-related sources of medication nonadherence in the Medicare population
Petroski, J., Strachan, K., Schluterman, N., & Doss, W. (2024) · Health Affairs Scholar · doi:10.1093/haschl/qxae152
Factors Influencing Patient Adherence to Antibiotic Therapy: a Systematic Review
Aulia, R., Wiedyaningsih, C., & Indriasih, E. (2026) · Journal of Pharmaceutical And Sciences · doi:10.36490/journal-jps.com.v9i3.1818
Corrêa, L. M., Mombelli, M. A., & Reis, R. A. (2026) · Interface - Comunicação Saúde Educação · doi:10.1590/interface.260093
Arison, M. L., Modeste, R. R. M., & Mabuda, T. (2026) · Trends in Nursing · doi:10.4102/tin.v6i1.42
Bari, M. A., Ahmad, Z., & Aziz, K. A. (2026) · IEEE International Conference on Quantum Photonics, Artificial Intelligence & Networking (QPAIN) · doi:10.1109/qpain69676.2026.11546451
Sri Raudoh Rezki, M. R., Khairunnisa, K., & ., W. (2026) · International Journal of Research and Review · doi:10.52403/ijrr.20260468
Dumbrell, J., Schofield, J., Steele, S., Gardiner, K., Craig, F., Richardson, J., Livingston, W., Neale, J., & Perkins, A. (2025) · Harm Reduction Journal · doi:10.1186/s12954-025-01336-3
IoT's Role in Revolutionizing Pillbox Technology
Singh, S., Sharma, A., -, S., Mukund, S. C., & Sharma, S. (2025) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815324457125010009
Wang, C., Yang, H., Zhou, H., Cheng, Y. S., Sun, Z., Cao, T., Yanxia, Z., Chen, Y., & Li, Z. (2025) · Medicine · doi:10.1097/md.0000000000045615
Improved Drug Adherence Improves Cardiac Outcomes after Myocardial Infarction in Diabetic Patients
Ji, W., Xue, L., Wang, H., Liu, X., & Li, T. (2025) · Kardiologiia · doi:10.18087/cardio.2025.9.n2937
Li, Y., Li, X., Ren, J., & Luo, H. (2026) · Patient Preference and Adherence · doi:10.2147/ppa.s585527 · Cited by 2
(2023) · Oxford University Press eBooks · doi:10.1093/med/9780197556269.002.0003
Sole-Moloto, T., Visser, M. J., Mostert, S., & Maduna, V. (2026) · Frontiers in Psychology · doi:10.3389/fpsyg.2026.1533804
Guo, J., Ning, F., Xiao, J., Pu, P., Zhao, Y., Zhang, W., & Wu, M. (2025) · Patient Preference and Adherence · doi:10.2147/ppa.s547265 · Cited by 1
Xiao, Y., Gessl, A. S., Nakata, C. C., Spanjol, J., Crawford, S. Y., Sharp, L. K., & Cui, A. S. (2024) · International Journal of Healthcare Management · doi:10.1080/20479700.2024.2358636 · Cited by 1
Ehrler, F., Tran, L. G., Hagberg, H., Meyer, P., & Blondon, K. (2023) · doi:10.2196/preprints.50693
Le, M. H., Hàng, Q. Đ., Triệu, T. B., NGUYEN, M. C., Lâm, Q. V., Tran, T. D., & Huỳnh, M. C. (2026) · Pharmacia · doi:10.3897/pharmacia.73.e205741
Faraji, A. R., Tahmasbi, S., Alavi, A., & Tahmasebi, F. (2026) · Global Social Welfare · doi:10.1007/s40609-026-00482-1
Artificial Autonomy or Relational Intelligence: How Relationality Matters in Health Monitoring
Ho, A. (2023) · Oxford University Press eBooks · doi:10.1093/med/9780197556269.003.0002
Elmokadem, E. M., Kandeel, B. A., Aly, M. M. M., & El-Kayal, M. (2026) · Future Journal of Pharmaceutical Sciences · doi:10.1186/s43094-026-00959-y
Kaikkonen, S., Kurhila, S., Komppa, J., Tolonen, H. M., & Kvarnström, K. (2025) · Journal of Pragmatics · doi:10.1016/j.pragma.2025.10.010
Self-citationValdivia Valdivia, J. A., & Matta, C. A. C. D. A. (2024) · Universidad Científica del Sur · doi:10.21142/tl.2024.3503
Wulandari, N., Hanifa, R. S., Balafas, S. E., et al. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5398617
The problem of non-compliance with treatment for chronic cardiovascular diseases
Васильевна, Л. М., Larina, V. N., & Геннадьевич, Л. В. (2026) · Meditsinskiy sovet = Medical Council · doi:10.21518/ms2026-152
Lopes, C. C. C., Ammar, Y. E., Nascimento, R. K., Bayer, V. M. L., Ries, E. F., Júnior, E. S. P., Dalcin, J. F., Cabral, L. F., & Sousa, M. A. F. D. (2023) · Journal of Community Medicine & Public Health · doi:10.29011/2577-2228.100307
Clinical Strategies, Management, and Challenges in Targeting CNS through Bioactive Compounds
Tripathi, S. M., Mishra, S. K., Malviya, R., & Ojha, S. (2025) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815324846125010008
Zhanzhigitova, K., Yeraliyeva, B., Buribayeva, Z., Cheboterenko, N., Abdiyev, N. M., Kiyekova, B., Erkinbekova, G., & Nurgazieva, G. (2026) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph23030279
McDonald, T. B., Upchurch, L., & Longwitz, A. (2026) · International Journal of Evidence-Based Healthcare · doi:10.1097/xeb.0000000000000637
Verrastro, V., Saladino, V., Sgroi, A., & Calaresi, D. (2026) · Behavioral Sciences · doi:10.3390/bs16091569
Al-Rawashdeh, A., Alqudah, R., Ibrahim, S., Safadi, W. A., Alrawi, S., Rawi, S. A., Malaeb, D. N., Hallit, S. R., & Barakat, M. M. (2026) · Pharmacy Practice · doi:10.18549/pharmpract.2026.2.3388
Valladales‐Restrepo, L. F., Londoño‐Cano, D. A., Muñoz-Velez, C. M., Soto-Romero, L. M., Tafur, M., Rojas-Varón, M. J., & Machado‐Alba, J. E. (2026) · Endocrine · doi:10.1007/s12020-025-04488-1 · Cited by 1
Pengaruh Edukasi Emo-Demo Terhadap Kepatuhan Minum Obat Pasien Hipertensi Pada Peserta Prolanis
Mahmuda, I. R., Roisah, R., & Salam, A. Y. (2023) · Jurnal Rumpun Ilmu Kesehatan · doi:10.55606/jrik.v3i2.1949
Adetunji, C. O., Adeniyi, O. O., Botha, A., & Herselman, M. E. (2022) · International Conference on Computational Science and Computational Intelligence (CSCI) · doi:10.1109/csci58124.2022.00303 · Cited by 1
Liao, Y. (2024) · American Journal of Health Behavior · doi:10.5993/ajhb.48.6.1 · Cited by 1
A Dedicated Nephrology Daycare Unit: A Step Toward a Patient-Centered Approach
Ankawi, G. (2024) · Cureus · doi:10.7759/cureus.67324 · Cited by 1
Widayati, A., Hadning, I., & Wulandari, E. T. (2025) · Scientific Reports · doi:10.1038/s41598-025-31978-z · Cited by 3
Gharaibeh, L. F., Alhariri, M., Smadi, S., Alalem, T., Riyati, H. A., Abu-safi, R., Abu-Al-Roos, R., Hilow, W., Hamideh, R., & Abu-Farha, R. (2026) · Frontiers in Public Health · doi:10.3389/fpubh.2026.1865416 · Cited by 1
Getnet, M., Gashaw, F., Salelew, E., Fanta, B., & Kelebie, M. A. (2026) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-026-03062-y
Sulistiyani, E., Nuphanudin, Khamidi, A., Kristanto, A., & Haq, M. S. (2025) · Jurnal Ilmiah Pendidikan Profesi Guru · doi:10.23887/jippg.v8i3.105035
Doles, M., Caswell, B., & Conty, N. (2024) · JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY · doi:10.1002/jac5.2033
Fostering Resilience in Children with Chronic Illnesses During and After Hospitalization
Wazevich, M., Justice, R. I., & Nabors, L. (2026) · Springer series on child and family studies · doi:10.1007/978-3-032-08523-8_9
Challenges in ensuring long-term care for individuals living with diabetes: a qualitative study
Iloonkashkooli, R., Setoodeh, G., Soltanian, M., Momennasab, M., Ansari, M., & Shirazi, Z. H. (2025) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-025-01724-3 · Cited by 2
Olumeko, I., Cheruvu, S. S., Ofili, S. C., & Abughosh, S. (2026) · Diabetology · doi:10.3390/diabetology7050087
Lanke, V., Trimm, K., Habib, B., & Tamblyn, R. M. (2024) · doi:10.2196/preprints.60822
Umaru, O., & Aremu, T. O. (2026) · Cureus · doi:10.7759/cureus.103859
AlHarthi, M. S. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1595308
Ensuring Dosage Adherence in the Digital Era of IoT and AI
Sharma, S., Tomar, D. S., Sunita, D., Yashwanth, K. K., & Sharma, A. (2025) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815324457125010012
Lindholm, T., Lias, N., Kvarnström, K., Holmström, A.-R., Toivo, T., Uusitalo, M., Nurmi, H. J., & Airaksinen, M. (2025) · Journal of Medical Internet Research · doi:10.2196/70133 · Cited by 1
Self-citationQualitative Methods in Pharmacy Practice Research
Hussain, R., Alomari, M., Ahmad, N. A., & Alshorman, K. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-26472-6.00194-7
Educational Curriculum to Improving Clinical Outcome On Gestational Diabetes During Pregnancy
Alsudairy, N. M., Tehaifah, Z. A., Abuhekmah, G. A., AlGhazal, Z. Y. Y., Abufaia, R. E., Alwdani, M. S., Alyami, B. H., Awad, H. H. A., aljohani, S. H., AL-Doaan, D. H., et al. (2023) · Saudi Medical Horizons Journal · doi:10.54293/smhj.v3i2.77
Hypertension management and drug-related problems. A case report of the 23-year history of Mr. Jonas
Trečiokienė, I., Pečeliūnienė, J., Wettermark, B., Gulbinovič, J., & Taxis, K. (2023) · Exploratory Research in Clinical and Social Pharmacy · doi:10.1016/j.rcsop.2023.100313 · Cited by 1
Sahu, N., Yadav, P., Kotla, R., & Goswami, A. (2025) · International journal of Nutrition Pharmacology Neurological Diseases · doi:10.4103/ijnpnd.ijnpnd_73_25
Relationship between illness perception and quality of life in prostate cancer survivors
Tajik, M., Salehi, S., & Nasrollah, S. (2026) · Journal of Translational Medical Research · doi:10.66224/jbums.33.1.62
Interdisciplinary Perspectives on Patient Adherence to Therapy: Findings from a Qualitative Study
González-García, P., Fernández-Seguín, L. M., Martínez, E. E., Fernández‐García, E., Gago-Valle, C., & García-Bernal, M.-I. (2026) · Healthcare · doi:10.3390/healthcare14142225 · Cited by 2
Heikkilä, J. M., Bergman, P., Jantunen, J., Salimäki, J., Pohjanoksa-Mäntylä, M., & Kauppi, P. (2023) · BMC Public Health · doi:10.1186/s12889-023-16423-y
Qazi, T. B., Yousuf, A. M., Khan, M. A., & Khan, S. M. S. (2025) · Indian Journal of Community and Family Medicine · doi:10.4103/ijcfm.ijcfm_98_24 · Cited by 1
Adherence to Disulfiram Therapy in Outpatients with Alcohol Dependence: A Mixed Methods Study
Meena, O., Kaloiya, G. S., Dhawan, A., & Sarkar, S. (2026) · Indian Journal of Social Psychiatry · doi:10.4103/ijsp.ijsp_366_24
Lee, C., Otunla, A. A., Brennan, Aronson, J. K., & Nunan, D. (2022) · medRxiv · doi:10.1101/2022.10.30.22281709
Ghasemnataj, Z., Paryad, E., Ghanbari, A., Leili, E. K., Ganji, G. F., & Noveiri, M. J. S. (2026) · Journal of Cardiac Surgery · doi:10.1155/jocs/7025243
Lundgren, E., Laurenius, A., Hedberg, S., Thorell, A., Hägg, M., Grehn, S., Spetz, K., Olbers, T., & Andersson, E. (2026) · Obesity Surgery · doi:10.1007/s11695-026-08550-3 · Cited by 1
Hlophe, L. D., Nyasulu, P. S., & Shumba, C. S. (2026) · PLoS ONE · doi:10.1371/journal.pone.0321907
Swartchick, C. B., & Langman, L. J. (2026) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2026.07.012
Tapak, L., Fard, H. H., Ramezani‐Doroh, V., & Afshari, M. (2025) · Current Women s Health Reviews · doi:10.2174/0115734048364356250722053424
Development and validation of the chemotherapy adherence assessment scale (CAAS)
Prakash, G. H., Doddaiah, S. K., Kiran, P. K., Arun, V., & Yadav, D. (2024) · Journal of Oncology Pharmacy Practice · doi:10.1177/10781552241291225 · Cited by 1
Pharmacology and the Exercise Professional: Understanding Implications of Client Medications
Chaney, L. R., & Bushman, B. A. (2025) · ACSMʼs Health & Fitness Journal · doi:10.1249/fit.0000000000001033
Corrêa, L. M., Mombelli, M. A., & Reis, R. A. (2026) · Interface - Comunicação Saúde Educação · doi:10.1590/interface.250178
The impact of health information on patient outcomes
Alhamoud, M. Y., Ziyad, K. S. S., & Alharbi, M. (2021) · International Journal of Health Sciences · doi:10.53730/ijhs.v5ns1.15349
Science Popularization Interventions on Rational Medication in Patients with Hyperuricemia
Bi, L., & Jiang, T. (2023) · American Journal of Health Behavior · doi:10.5993/ajhb.47.1.16
Ghabach, M. B., Sacre, H., Basma, S., Haddad, C., Akel, M., Aoun, R., & Salameh, P. (2026) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-026-01948-x · Cited by 1
González, M. L., Hernández, M. Á. C., & Martín, M. F. (2025) · Patient Preference and Adherence · doi:10.2147/ppa.s524773 · Cited by 1
Medication Adherence Among Patients With Type 2 Diabetes at the Upper West Regional Hospital, Ghana
Arhin, I. K., Amponsah, L. B., Fenny, B., & Egbenya, D. L. (2026) · Health Science Reports · doi:10.1002/hsr2.71848 · Cited by 2
Frigaard, C., Ofstad, E. H., Menichetti, J., Schirmer, H., Bjørnstad, H., Simonsen, T. B., Gulbrandsen, P., & Gerwing, J. (2026) · Patient Education and Counseling · doi:10.1016/j.pec.2026.109655 · Cited by 1
Schleef, J., & Ortíz, M. S. (2024) · Behavioral Medicine · doi:10.1080/08964289.2024.2406308
Public Knowledge and Factors Associated With Familiarity of Treatments for Rhinosinusitis
Gallagher, T. J., Shah, R., Koh, M., Julien, C., Lin, M. E., & Hur, K. (2025) · OTO Open · doi:10.1002/oto2.70091
Esmaeeli, E., Ataee, E., Sajjadi, H., & Mohammadzadeh, N. (2023) · Research Square · doi:10.21203/rs.3.rs-3161280/v1
Zhang, X., Wen, X., Zhou, Y., Huang, M., Yao, D., Hu, X., Lv, Q., Chen, C., & Song, Y. (2026) · International Journal for Equity in Health · doi:10.1186/s12939-026-02913-z
Metadata
- Authors
- Kvarnström, K., Westerholm, A., Airaksinen, M., & Liira, H.
- Affiliations
- University of Helsinki (FI)
- Corresponding author
- Kvarnström, Kirsi
- Venue
- Pharmaceutics
- Publisher
- MDPI AG
- Published
- 2021-07-20
- Volume
- 13
- Issue
- 7
- Pages
- 1100
- ISSN
- 1999-4923 (ISSN-L)
- PMC
- PMC8309154
- OpenAlex
- W3184262661
- Cited by
- 470
- References
- 87
- Citations by year
- 2026: 99 · 2025: 144 · 2024: 113 · 2023: 82 · 2022: 29 · 2021: 3
- FWCI
- 13.72
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Pharmaceutics (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Työväentutkimus Vuosikirja (submittedVersion)
- Funders
- The Foundation for Municipal Development, Finland (3.6.2019)
- Topics
- Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
- Health Sciences › Health Professions › Pharmacy › Pharmacy and Medical Practices
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Keywords
- medication adherence, chronic disease, patient factors, barriers to adherence, facilitators of adherence, patient-provider communication, trust in healthcare providers, social support, sociocultural factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.